Physician profile
Ujjaval M Patel
NPI 1083664015
$2,947.75
in general payments reported to CMS, 2019-2025
23 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,488 · 2020: $125 · 2021: $208 · 2022: $354 · 2023: $376 · 2024: $264 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,078.19 | 2019-2023 | Impella |
| Irhythm Technologies, INC. | $246.36 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Amgen INC. | $210.54 | 2020-2025 | Repatha, Repatha |
| Abbott Laboratories | $191.22 | 2019-2023 | Cardiomems |
| Livanova USA, INC. | $152.02 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $139.51 | 2022-2024 | Lifevest |
| Pfizer INC. | $110.33 | 2019-2022 | |
| Medtronic, INC. | $105.35 | 2021-2025 | Hawkone |
| Janssen Biotech, INC. | $97.68 | 2019 | |
| Novo Nordisk INC | $94.65 | 2022-2024 | Ozempic, Wegovy |
| Medtronic USA, INC. | $77.72 | 2019 | |
| Medtronic Vascular, INC. | $65.66 | 2020 | |
| Novartis Pharmaceuticals Corporation | $56.18 | 2022-2025 | |
| Boston Scientific Corporation | $54.78 | 2021-2022 | |
| Shockwave Medical, INC | $44.99 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $44.57 | 2020-2023 | |
| Teleflex LLC | $43.01 | 2020-2025 | Guideliner |
| Recor Medical INC | $29.38 | 2025 | Paradise Ultrasound Renal Denervation System |
| Cardinal Health 200 LLC | $28.77 | 2019 | |
| Cardiva Medical, INC. | $24.06 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Acist Medical Systems, INC. | $20.92 | 2023 | |
| Penumbra, INC. | $16.69 | 2025 | Indigo System |
| Vital Connect, INC | $15.17 | 2025 | Vitalpatch Rtm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ujjaval Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.